Trial Profile
An Open-Label, Single-Arm, Multicenter Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2023
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary) ; Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Registrational; Therapeutic Use
- Acronyms PEACH
- Sponsors UCB Japan
- 28 Jul 2023 Status changed from active, no longer recruiting to completed.
- 20 Sep 2022 Planned End Date changed from 1 Dec 2023 to 25 Dec 2023.
- 08 Feb 2022 Planned End Date changed from 1 Nov 2023 to 1 Dec 2023.